Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections

Phase 3 Completed 1205 enrolled Tetraphase Pharmaceuticals, Inc

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the efficacy, safety, and pharmacokinetics of eravacycline compared to ertapenem in treating participants with complicated urinary tract infections (cUTI).

Timeline

Start: 2017-01
Primary completion: 2017-12
Completion: 2018-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Eravacycline	Small molecule	—	Intravenous
Comparator	Ertapenem	Small molecule	—	Intravenous
Background	Levofloxacin	Small molecule	—	Oral

Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections

Summary

Timeline

Drugs

Indications